We are live on
!
Find out more
NovoCure
NVCR
NVCR
222 hedge funds and large institutions have $1.08B invested in NovoCure in 2026 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 76 increasing their positions, 75 reducing their positions, and 49 closing their positions.
New
Increased
Maintained
Reduced
Closed
48% more call options, than puts
Call options by funds: $12.2M | Put options by funds: $8.24M
1.51% more ownership
Funds ownership: 85.38% → 86.89% (+1.5%)
1% more repeat investments, than reductions
Existing positions increased: 76 | Existing positions reduced: 75
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
7% less funds holding
Funds holding: 238 → 222 (-16)
13% less capital invested
Capital invested by funds: $1.24B → $1.08B (-$159M)
22% less first-time investments, than exits
New positions opened: 38 | Existing positions closed: 49
Holders
222
Holders Change
-16
Holders Change %
-6.72%
% of All Funds
2.73%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
38
Increased
76
Reduced
75
Closed
49
Calls
$12.2M
Puts
$8.24M
Net Calls
+$3.97M
Net Calls Change
-$6.99M
Top Buyers
| 1 |
Wells Fargo
San Francisco,
California
|
+$35.1M |
| 2 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$24.5M |
| 3 |
SG Americas Securities
New York
|
+$12.1M |
| 4 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$11.5M |
| 5 |
JP Morgan Chase
New York
|
+$6.59M |
Top Sellers
| 1 |
American Century Companies
Kansas City,
Missouri
|
-$10.5M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$7.37M |
| 3 |
Millennium Management
New York
|
-$6.94M |
| 4 |
Morgan Stanley
New York
|
-$6.6M |
| 5 |
Goldman Sachs
New York
|
-$5.4M |
